[ Price : $8.95]
AstraZeneca urges FDA to provide more detailed guidance or recommendations on how early in the drug development process sponsors s...[ Price : $8.95]
FDA accepts for review a Sun Pharmaceutical Industries NDA for deuruxolitinib, an investigational oral selective inhibitor of Janu...[ Price : $8.95]
Federal Register notice: FDA announces the revocation of two Monkeypox-related Emergency Use Authorizations after the authorizatio...[ Price : $8.95]
Federal Register notice: FDA corrects a 9/19 notice entitled Food and Drug Administration Information Technology Strategy; Request...[ Price : $8.95]
FDA approves Novartis intravenous Cosentyx (secukinumab) formulation for treating adults with psoriatic arthritis, ankylosing spon...[ Price : $8.95]
Sen. Richard Blumenthal (D-CT) calls on the Justice Department to take action against Philips Respironics after a recent investiga...[ Price : $8.95]
FDA approves an Arcutis Biotherapeutics supplemental NDA to expand the indication for Zoryve (roflumilast) cream 0.3% for the topi...[ Price : $8.95]
Syndax Pharmaceuticals says new positive data justifies stopping the pivotal AUGMENT-101 trial of revumenib in adult and pediatric...